Leading wellness revolution from- the-front we prevent diseases from developing altogether.
A Quality par-excellence, delivering seamlessly is our hallmark. Adherence to established quality standards assures safety and efficacy of drug products.
Breaking new grounds our manufacturing prowess is at-par with the 'Best in the World'.
We manufacture the complete array of finished dosage forms; producing everything from tablets, capsules, soft gels and injectables, to ointments, dry syrups, dry powder and granule filled sachets.
Regulatory Approvals Received and Planned for
Established in 1986, Ind-Swift is a research driven pharmaceutical group that produces world class finished dosage forms, active pharmaceutical ingredients, and intermediates. Over the years, it has moved forward aggressively, consistently winning new customers worldwide and making inroads into challenging new markets and regions.
Combining cutting edge innovation with dynamic marketing, Ind-Swift has already become a US$ 450 million entity. In fact, it is confidently eyeing the one billion dollar revenue mark by 2020.
The Group's multiple state-of-the-art production facilities, at home and abroad, meet stringent international norms -- including those of the USFDA, UK MHRA, and the WHO.
Ind-Swift Ltd, is listed on the Bombay Stock Exchange and the National Stock Exchange.
Its business successes apart, the group sees itself as a stakeholder in the service to humanity, offering quality pharmaceuticals that mitigate illness and suffering, and contribute to a healthier and better world.
Copyright © 2013 - All Rights Reserved - Ind-Swift Ltd. GBU